Skip to main content
. 2018 Jan 11;14(1):47–56. doi: 10.7150/ijbs.22209

Table 1.

Relationships of SHP2 mRNA levels with clinico-pathological parameters in lung adenocarcinoma patients.

SHP2
Variables No. Low High P
Age
≤60 16 5 (31) 14 (69) 0.044
>60 20 13 (65) 7 (35)
Gender
Female 20 10 (50) 10 (50) 1.000
Male 16 8 (50) 8 (50)
Smoking status
Nonsmokers 29 14 (48) 15 (52) 1.000
Smokers 7 4 (57) 3 (43)
Stage
I 13 7 (54) 6 (46) 0.729
II &III 23 11 (48) 12 (52)